Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:03:50.130Z.
Calculation as of: 2026-10-06T17:03:50.130Z.
Quote observation: 2026-10-06T17:00:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 64600f38e310d2eb3cd81a0b95bf77f6abd31b9de5548b9cdd3f3c9d46967593
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
PROCEPT BioRobotics Corporation
Market Cap
$991.20M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$983.38M
Free Cash Flow Yield
18.25%
TTM Avg
13.64%
3Y Avg
14.16%
5Y Avg
10.28%
Market Cap
$979.81M
Free Cash Flow Yield
N/A
TTM Avg
3.50%
3Y Avg
3.50%
5Y Avg
3.50%
Market Cap
$979.53M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$966.65M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02B
Free Cash Flow Yield
3.11%
TTM Avg
2.95%
3Y Avg
2.95%
5Y Avg
2.95%
Market Cap
$1.03B
Free Cash Flow Yield
N/A
TTM Avg
3.10%
3Y Avg
4.04%
5Y Avg
3.98%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation (PRCT) | $991.20M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $983.38M | 18.25% | 13.64% | 14.16% | 10.28% |
| MeiraGTx Holdings plc (MGTX)vs › | $979.81M | N/A | 3.50% | 3.50% | 3.50% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.53M | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $966.65M | N/A | N/A | N/A | N/A |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 3.11% | 2.95% | 2.95% | 2.95% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | N/A | 3.10% | 4.04% | 3.98% |
| Savara Inc. (SVRA)vs › | $952.91M | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.03B | N/A | 17.35% | 119.04% | 59.35% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
